Invacare Corporation (IVC) Receives FDA Acceptance of Second Certification Audit Related to Consent Decree
7/16/2013 10:25:23 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) today announced that the United States Food and Drug Administration (FDA) has found acceptable the Company’s second third-party certification audit relating to design control systems at the Company’s Corporate and Taylor Street facilities. This acceptance permits the Company to resume design activities for power wheelchairs and power beds.
Help employers find you! Check out all the jobs and post your resume.
comments powered by